Cargando…
The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0–24 and 25–48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073083/ https://www.ncbi.nlm.nih.gov/pubmed/33920566 http://dx.doi.org/10.3390/biom11040591 |
_version_ | 1783684052062044160 |
---|---|
author | Sternby, Hanna Hartman, Hannes Thorlacius, Henrik Regnér, Sara |
author_facet | Sternby, Hanna Hartman, Hannes Thorlacius, Henrik Regnér, Sara |
author_sort | Sternby, Hanna |
collection | PubMed |
description | Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0–24 and 25–48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-values) of IL-1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α were calculated. Differences between severity groups, predictive capacity of the biomarkers and association with severe disease were analyzed. Paired comparison of samples (n = 115) taken at 0–24 and 25–48 h after onsets of AP showed a change over time for IL-1β, IL-6, IL-8 and IL-10 (p < 0.05) and a significant difference between severity groups after 24 h. In ROC-analysis an IL-6 cut-off level of 196.6 pg/mL could differentiate severe AP (sensitivity 81.9, specificity 91.3). The delta-values of IL-1β and IL-6 were significantly associated with severe outcomes (odds ratios 1.085 and 1.002, respectively). Data of this work demonstrate a distinct change in IL-1β, IL-8, IL-10 and IL-6 over the first 48 h after onset of AP. The temporal development of biomarkers can assist in the early stratification of the disease. Herein IL-1β and IL-6 were associated with severe disease, however the prognostic capacity of investigated biomarkers is low. |
format | Online Article Text |
id | pubmed-8073083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80730832021-04-27 The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis Sternby, Hanna Hartman, Hannes Thorlacius, Henrik Regnér, Sara Biomolecules Article Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0–24 and 25–48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-values) of IL-1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α were calculated. Differences between severity groups, predictive capacity of the biomarkers and association with severe disease were analyzed. Paired comparison of samples (n = 115) taken at 0–24 and 25–48 h after onsets of AP showed a change over time for IL-1β, IL-6, IL-8 and IL-10 (p < 0.05) and a significant difference between severity groups after 24 h. In ROC-analysis an IL-6 cut-off level of 196.6 pg/mL could differentiate severe AP (sensitivity 81.9, specificity 91.3). The delta-values of IL-1β and IL-6 were significantly associated with severe outcomes (odds ratios 1.085 and 1.002, respectively). Data of this work demonstrate a distinct change in IL-1β, IL-8, IL-10 and IL-6 over the first 48 h after onset of AP. The temporal development of biomarkers can assist in the early stratification of the disease. Herein IL-1β and IL-6 were associated with severe disease, however the prognostic capacity of investigated biomarkers is low. MDPI 2021-04-17 /pmc/articles/PMC8073083/ /pubmed/33920566 http://dx.doi.org/10.3390/biom11040591 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sternby, Hanna Hartman, Hannes Thorlacius, Henrik Regnér, Sara The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis |
title | The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis |
title_full | The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis |
title_fullStr | The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis |
title_full_unstemmed | The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis |
title_short | The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis |
title_sort | initial course of il1β, il-6, il-8, il-10, il-12, ifn-γ and tnf-α with regard to severity grade in acute pancreatitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073083/ https://www.ncbi.nlm.nih.gov/pubmed/33920566 http://dx.doi.org/10.3390/biom11040591 |
work_keys_str_mv | AT sternbyhanna theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT hartmanhannes theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT thorlaciushenrik theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT regnersara theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT sternbyhanna initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT hartmanhannes initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT thorlaciushenrik initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis AT regnersara initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis |